Related Experiment Videos
Once-daily antiretroviral therapy: Spanish Consensus Statement
1Hospital Universitario 12 de Octubre, 28041 Madrid, Spain. fpulido@ya.com
The Journal of Antimicrobial Chemotherapy
|September 10, 2005
Summary
Once-daily antiretroviral therapy (ART) offers potential benefits for patient adherence and quality of life. While options are currently limited, this dosing strategy is a viable alternative when effective drug combinations are available.
Area of Science:
- Pharmacology
- Infectious Diseases
- Public Health
Background:
- Once-daily antiretroviral therapy (ART) is gaining interest for improving patient adherence and quality of life.
- Clinical application of once-daily ART faces challenges despite its potential benefits.
Framework:
- A consensus among 248 Spanish experts evaluated the characteristics and possibilities of once-daily ART.
- The study focused on expert opinions regarding the efficacy and applicability of simplified ART regimens.
Implementation:
- Once-daily ART can enhance adherence and efficacy, particularly for patients with specific social or personal circumstances.
- Current first-choice ART combinations allow for some once-daily regimens, but options remain limited.
- Future drug development could expand the use of once-daily ART, including for patients requiring rescue therapy.
Implications:
- Once-daily ART presents a valuable alternative to multiple daily dosing regimens when potent and active drug combinations are accessible.
- Optimizing ART administration schedules is crucial for improving long-term treatment outcomes and patient well-being.